Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice

British Journal of Cancer

Volumn 85, Issue 6, 2001, Pages 917-923

  Benedetto, M Di ^a   Kourbali, Y ^a   Starzec, A ^b   Vassy, R ^b   Jozefonvicz, J ^c   Perret, G ^b   Crepin, M ^a   Kraemer, M ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b Equipe de Pharmacologie   (France)

^c CNRS   (France)

Author keywords

Breast cancer; Carboxymethyl benzylamide dextran derivative (CMDB); MCF 7ras; Sodium phenylacetate (NaPa); Synergism

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOXYMETHYLBENZYLAMIDE DEXTRAN DERIVATIVE; DEXTRAN DERIVATIVE; PHENYLACETATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA REPLICATION; DOSE TIME EFFECT RELATION; DRUG POTENTIATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; DEXTRANS; DRUG COMBINATIONS; FEMALE; FIBROBLASTS; GROWTH SUBSTANCES; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PHENYLACETATES; PROTO-ONCOGENE PROTEINS P21(RAS); TUMOR CELLS, CULTURED;

EID: 0035860139     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1993     Document Type: Article

References (27)

1. Sodium phenylacetate induces growth inhibition and Bcl 2 down regulation and apoptosis in MCF-7ras cells in vitro and in nude mice
2. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras by sodium phenylacetate and tamoxifene combination
3. 17 β estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane
4. Inhibitory effect of dextran derivatives in vitro on the growth characteristics of premalignant and malignant human mammary epithelial cell lines
5. Inhibition of human breast epithelial HBL 100 cell proliferation by a dextran derivative (CMDB7) with FGF2 autocrine loop
6. The supression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumor angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)
7. Inhibition of MCF-7ras tumor growth by benzylamide dextran: Blockage of the paracrine effect and receptor binding of transforming growth factor β1 and platelet-derived growth factor-BB
8. Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB 435 breast carcinoma xenografted in fad pad and its lung metastases in nude mice
9. Criteria for analysing interaction between biologically active agents
10. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines
11. Phase 11 study of phenylacetate in patients with recurrent malignant glioma: A north American brain tumor concortium
12. Synthesis and structure-anticoagulant property relationships of functionalized dextrans: CMDBS
13. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17β estradiol or V-Ha-ras oncogene
14. Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro
15. Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and nerosis
16. Evidence that TGF β is a hormonally regulated negative growth factor in human breast cancer cell lines
17. Anticoagulant activity of dextran derivatives. Part 1: Synthesis and characterization
18. Rapid colorimetric assay for cell growth and survival: Application to proliferation and cytotoxicity assays
19. Lipid metabolism as a target for brain cancer therapy: Synergistic activity of lovastatin and sodium phenylacetate and phenylbutyrate
20. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by non toxic pharmalogical concentration of phenylacetate
21. Selective activity of phenylacetate against malignant gliomas: Ressemblance to fetal brain damage in phenylketonuria
22. Phenylacetate and phenylbutyrate as novel, nontoxic differenciation inducers
23. Peroxisome proliferator-activated receptor gamma as a novel target in cancer therapy: Binding and activation by an aromatic fatty acid with clinical antitumor activity
24. H
25. Human malignant tumors of the breast as compared to their respective normal tissue have elevated expression of the Harvey ras oncogene
26. A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer
27. Sodium phenylacetate modulates the synthesis of autocrine and paracrine growth factors secreted by breast cancer cell lines